Synergism of ApoE4 and systemic infectious burden is mediated by the APOE-NLRP3 axis in Alzheimer's disease

被引:0
|
作者
Liu, Xue-Ting [1 ]
Chen, Xiu [1 ]
Zhao, Na [1 ]
Geng, Fan [1 ]
Zhu, Meng-Meng [1 ]
Ren, Qing-Guo [2 ]
机构
[1] Southeast Univ, Sch Med, Nanjing, Peoples R China
[2] Southeast Univ, Affiliated ZhongDa Hosp, Dept Neurol, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
activation of microglia; Alzheimer's disease; apolipoprotein E; NLRP3; inflammasome; NLRP3 INFLAMMASOME ACTIVATION; NEURODEGENERATION; MICROGLIA; NEUROINFLAMMATION; CONTRIBUTES; AUTOPHAGY; BETA;
D O I
10.1111/pcn.13704
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Systemic infections are associated with the development of AD, especially in individuals carrying the APOE4 genotype. However, the detailed mechanism through which APOE4 affects microglia inflammatory response remains unclear. Methods: We obtained human snRNA-seq data from the Synapse AD Knowledge Portal and assessed the DEGs between APOE3 and APOE4 isoforms in microglia. To verify the interaction between ApoE and infectious products, we used ApoE to stimulate in vitro and in vivo models in the presence or absence of LPS (or ATP). The NLRP3 gene knockout experiment was performed to demonstrate whether the APOE-NLRP3 axis was indispensable for microglia to regulate inflammation and mitochondrial autophagy. Results were evaluated by biochemical analyses and fluorescence imaging. Results: Compared with APOE3, up-regulated genes in APOE4 gene carriers were involved in pro-inflammatory responses. ApoE4-stimulation significantly increased the levels of NLRP3 inflammasomes and ROS in microglia. Moreover, compared with ApoE4 alone, the co-incubation of ApoE4 with LPS (or ATP) markedly promoted pyroptosis. Both NF-kappa B activation and mitochondrial autophagy dysfunction were contributed by the increased level of NLRP3 inflammasomes induced by ApoE4. Furthermore, the pathological impairment induced by ApoE4 could be reversed by NLRP3 KO. Conclusions: Our study highlights the importance of NLRP3 inflammasomes in linking ApoE4 with microglia innate immune function. These findings not only provide a molecular basis for APOE4-mediated neuroinflammatory but also reveal the potential reason for the increased risk of AD in APOE4 gene carriers after contracting infectious diseases.
引用
收藏
页码:517 / 526
页数:10
相关论文
共 50 条
  • [1] Commentary: Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
    Dzianok, Patrycja
    Kublik, Ewa
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [2] Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease
    Theendakara, Veena
    Peters-Libeu, Clare A.
    Bredesen, Dale E.
    Rao, Rammohan V.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 5243 - 5254
  • [3] Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
    Veena Theendakara
    Clare A. Peters-Libeu
    Dale E. Bredesen
    Rammohan V. Rao
    Molecular Neurobiology, 2018, 55 : 5243 - 5254
  • [4] From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer's Disease
    Dias, Daniela
    Portugal, Camila Cabral
    Relvas, Joao
    Socodato, Renato
    CELLS, 2025, 14 (04)
  • [5] Cellular Senescence and ApoE4: Their Repercussions in Alzheimer's Disease
    Tecalco-Cruz, Angeles C.
    Zepeda-Cervantes, Jesus
    Lopez-Canovas, Lilia
    Oriando Ramirez-Jarquin, Josue
    Pedraza-Chaverri, Jose
    Briones-Herrera, Alfredo
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (09) : 778 - 785
  • [6] Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
    Huang, Yu-Wen Alvin
    Zhou, Bo
    Nabet, Amber M.
    Wernig, Marius
    Sudhof, Thomas C.
    JOURNAL OF NEUROSCIENCE, 2019, 39 (37) : 7408 - 7427
  • [7] APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
    Ayyubova, Gunel
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (03) : 342 - 352
  • [8] APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease
    Parhizkar, Samira
    Holtzman, David M.
    SEMINARS IN IMMUNOLOGY, 2022, 59
  • [9] Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Martiskainen, Henna
    Haapasalo, Annakaisa
    Kurkinen, Kaisa M. A.
    Pihlajamaki, Jussi
    Soininen, Hilkka
    Hiltunen, Mikko
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 781 - 794
  • [10] APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Md. Sahab Uddin
    Md. Tanvir Kabir
    Abdullah Al Mamun
    Mohamed M. Abdel-Daim
    George E. Barreto
    Ghulam Md Ashraf
    Molecular Neurobiology, 2019, 56 : 2450 - 2465